Botulinum toxin A in the overactive bladder: current status and future directions.
about
Anticholinergic drugs versus other medications for overactive bladder syndrome in adultsThe management of childhood urinary incontinence.Treatment success for overactive bladder with urinary urge incontinence refractory to oral antimuscarinics: a review of published evidenceThe surgical management of the refractory overactive bladder.Recent advances in management of bladder overactivity.Jaundice following intravesical botulinum toxin - a previously unreported complication.New insights into the pharmacology of the bladderDetection of botulinum neurotoxin serotype A, B, and F proteolytic activity in complex matrices with picomolar to femtomolar sensitivity.Efficacy and safety of onabotulinumtoxinA in treating neurogenic detrusor overactivity: a systematic review and meta-analysis.Effect of weight loss on urinary incontinence in womenBotulinum a toxin/dimethyl sulfoxide bladder instillations for women with refractory idiopathic detrusor overactivity: a phase 1/2 studyUrinary incontinence: pharmacotherapy options.Contemporary management of overactive bladder.The efficacy and safety of onabotulinumtoxinA in treating idiopathic OAB: A systematic review and meta-analysis.Efficacy and duration of response to botulinum neurotoxin A (onabotulinumA) as a treatment for detrusor overactivity in women.Efficacy of onabotulinum toxin A injection in pediatric patients with non-neurogenic detrusor overactivity.Treatment satisfaction and goal attainment with onabotulinumtoxinA in patients with incontinence due to idiopathic OAB.Botulinum Toxin A Intradetrusor Injection for Treating Neurogenic Detrusor Overactivity, A Single Centre Experience.Isolation and quantification of botulinum neurotoxin from complex matrices using the BoTest matrix assays.Hematuria following Botox treatment for upper limb spasticity: a case report.A systematic review and meta-analysis of effectiveness and safety of therapy for overactive bladder using botulinum toxin A at different dosages.Adolescence transitional care in neurogenic detrusor overactivity and the use of OnabotulinumtoxinA: A clinical algorithm from an Italian consensus statement.Can Intradetrusor OnabotulinumtoxinA Injections Alter Heart Function in Patients with Cardiac Arrhythmia?
P2860
Q24243527-F100CAD1-B877-4233-92E4-9AECBACCCD69Q30424701-0CE0586E-452F-405C-B0F9-7F93AB2508FBQ30906698-BBC73610-729F-4055-8EA7-EFDE771BC78AQ34124059-B6808EE0-7BDB-468F-8E0D-6C537042FA96Q34167658-50FC9C83-F4EE-47E5-A6C7-A196CBD30454Q34527471-141CD493-EB69-4165-9DB4-505A0DA98A11Q34931019-7531F2EF-3394-497F-9BBA-2904EEECCA5DQ36361811-9552EDD9-6923-48D0-A515-B66B2CD1A87EQ36804908-F9E97DCD-B858-4190-8D53-0967C468FA5CQ37283761-83ECFA34-FC18-40E9-ADEC-D229D834D873Q37285555-4B197784-6D27-4A66-932D-AA47F7AFA65DQ37884579-C4465D45-B945-4E1B-AD16-689473EB4337Q37982213-50C747E4-6B8D-4A53-9DC0-8BD7D4ED809EQ38200003-A789338B-7756-485D-B029-7C38B2510FBFQ38545297-50516ED9-9F38-4FB2-9150-112F41D0B506Q38962547-A615539F-1153-486F-B685-9C2826ECC98EQ39252789-939DA76B-5B67-4B46-906B-4AE72E2CA8E6Q40215511-5F14943F-406E-49A3-86C9-DD8D8294C52AQ41908266-D91A953D-5981-4C40-9AEC-8C372D0F7E74Q43245023-7172A1BB-6189-4994-B9C6-6E4CF78AA965Q45788137-91D04EDE-40CA-4A18-8560-4B01972FC3E2Q47698116-9FAA5AB0-1B35-4890-83F4-BFB5F71C8AF4Q58757054-33C06E46-513F-448D-999B-667795191C29
P2860
Botulinum toxin A in the overactive bladder: current status and future directions.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Botulinum toxin A in the overactive bladder: current status and future directions.
@ast
Botulinum toxin A in the overactive bladder: current status and future directions.
@en
type
label
Botulinum toxin A in the overactive bladder: current status and future directions.
@ast
Botulinum toxin A in the overactive bladder: current status and future directions.
@en
prefLabel
Botulinum toxin A in the overactive bladder: current status and future directions.
@ast
Botulinum toxin A in the overactive bladder: current status and future directions.
@en
P2860
P1433
P1476
Botulinum toxin A in the overactive bladder: current status and future directions.
@en
P2093
Peter K Sand
P2860
P304
P356
10.1111/J.1464-410X.2007.06575.X
P577
2007-02-01T00:00:00Z